Announcements Trials
Browse Landscape

Phase

Phase 4 3Phase 3 2

Status

Completed 5Unknown 2Recruiting 1

Sponsor Class

OTHER 5

Study Type

Interventional 5Observational 1

Sponsor

Cancer Type

Other 3

Conditions

Polycystic Ovary Syndrome 5Obesity 2Weight Loss 1Prediabetic State 1Obesity, Abdominal 1Infertility, Female 1Infertility 1Glucose Intolerance 1Cardiovascular Diseases 1

Interventions

Cyclophosphamide 1488Cisplatin 1410Paclitaxel 1316Radiotherapy 1259Carboplatin 1247Gemcitabine 1214Docetaxel 1110Bevacizumab 1029Fluorouracil 894Doxorubicin 786Dexamethasone 746Rituximab 719Capecitabine 716Oxaliplatin 700pembrolizumab 673Etoposide 673Irinotecan 634Filgrastim 621Cytarabine 584Leucovorin 578Nivolumab 557Vincristine 510Prednisone 474Cetuximab 464Bortezomib 457Erlotinib Hydrochloride 456Trastuzumab 448Methotrexate 437Lenalidomide 426Pemetrexed 419

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Completed × Interventional × Liraglutide × Clear all
NCT05965908 2026-03-06

Effect of Liraglutide in Obese Women With Polycystic Ovary Syndrome

Beni-Suef University

Phase 3 Completed
150 enrolled

Polycystic Ovary Syndrome

NCT03480022 2021-06-07

SAXAPCOS

Woman's

Phase 3 Completed
88 enrolled 35 charts
Other

Polycystic Ovary Syndrome, Prediabetic State, Weight Loss, Glucose Intolerance, Obesity, Abdominal

NCT02073929 2019-02-28

LIPT

Herlev Hospital

Phase 4 Completed
72 enrolled 18 charts

Cardiovascular Diseases, Polycystic Ovary Syndrome

NCT03353948 2017-11-27

The Effect of a Liraglutide on IVF in Obese PCOS

University Medical Centre Ljubljana

Phase 4 Completed
30 enrolled
Other

Infertility, Infertility, Female, Obesity, Polycystic Ovary Syndrome

NCT02909933 2016-09-21

Low Dose Liraglutide and Metformin vs. High Dose Liraglutide Alone in Treatment of Obesity

University Medical Centre Ljubljana

Phase 4 Completed
30 enrolled
Other

Obesity, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡